Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial

Circulation

Volumn 126, Issue 11 SUPPL.1, 2012, Pages

  Vieira, Ricardo D'Oliveira ^a   Hueb, Whady ^a   Gersh, Bernard J ^b   Lima, Eduardo Gomes ^a   Pereira, Alexandre Costa ^a   Rezende, Paulo Cury ^a   Garzillo, Cibele Larrosa ^a   Hueb, Alexandre Ciappina ^a   Favarato, Desiderio ^a   Soares, Paulo Rogério ^a   Ramires, José Antonio Franchini ^a   Filho, Roberto Kalil ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MAYO CLINIC   (United States)

Author keywords

coronary revascularization; stable coronary artery disease; survival

Indexed keywords

ADULT; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CORONARY ARTERY BYPASS; CORONARY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REOPERATION; STENTS; TREATMENT OUTCOME;

EID: 84866443094     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.084236     Document Type: Article

References (16)

1. Ong ATL, Serruys PW. Complete revascularization: coronary artery bypass graft surgery versus percutaneous coronary intervention. Circulation. 2006; 114:249-255.
2. Zimarino M, Calafiore AM, De Caterina R. Complete myocardial revascularization: between myth and reality. Eur Heart J. 2005;26:1824-1830.
3. Hueb WA, Ramires JAF. Complete, incomplete or no myocardial revascularization. Arq Bras Cardiol. 2006;87:e144-e146.
4. Bell MR, Gersh BJ, Schaff HV, Holmes DR, Fisher LD, Alderman EL, Myers WO, Parsons LS, Reeder GS. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery: a report from the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1992;86:446-457.
5. Aziz A, Lee AM, Pasque MK, Lawton JS, Moazami N, Damiano RJ, Moon MR. Evaluation of revascularization subtypes in octogenarians undergoing coronary artery bypass grafting. Circulation. 2009;120: S65-S69.
6. Hannan EL, Racz M, Holmes DR, King SB, Walford G, Ambrose JA, Sharma S, Katz S, Clark LT, Jones RH. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006;113:2406-2412.
7. Hannan EL, Wu C, Walford G, Holmes DR, Jones RH, Sharma S, King SB. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. J Am Coll Cardiol Interv. 2009;2:17-25.
8. Ijsselmuiden AJJ, Ezechiels J, Westendorp ICD, Tijssen JGP, Kiemeneij F, Slagboom T, Wieken R, Tangelder G, Seruys P, Laarman G. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Am Heart J. 2004;148:467-474.
9. Bourassa MG, Kip KE, Jacobs AK, Jones RH, Sopko G, Rosen AD, Sharaf BL, Schwartz L, Chaitman BR, Alderman EL, Holmes DR, Roubin GS, Detre KM, Frye RL, for the BARI Investigators. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The bypass angioplasty revas-cularization investigation (BARI). J Am Coll Cardiol. 1999;33: 1627-1636.
10. van den Brand MJBM, Rensing BJWM, Morel MM, Foley DP, Valk V, Breeman A, Suryapranata H, Haalebos MMP, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW. The effect of completeness of revascularization on event-free survival at one year in the arts trial. J Am Coll Cardiol. 2002;39:559-564.
11. Hueb W, Soares PR, Gersh BJ, Cesar LAM, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JAF. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004;43:1743-1751.
12. Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha ASC, Hueb AC, Ramires JAF. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010;122:949-957.
13. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO, Gibbons RJ, Alpert JP, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC Jr. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 2001; 37:2239.
14. Martuscelli E, Clementi F, Gallagher MM, D'Eliseo A, Chiricolo G, Nigri A, Marino B, Romeo F; on behalf of CABRI trialists. Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded: data from the CABRI trial. Eur J Cardiothorac Surg. 2008;33:4-8.
15. Teirstein PS. The dueling hazards of incomplete revascularization and incomplete data. Circulation. 2006;113:2380-2382.
16. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217-225.